Wang Zhe**, Aixia Wang***, Xueshan Zhang* **National HIV Research Laboratory, Beijing China ***Beijing Union Medical University Hospital, Beijing, China

Abstract: A new physiotherapy, by a Multi-Frequency bio-spectrum lamp (Healing Lamp), recently was applied to treat l0 AIDS patients for 1 month. MF lamp can produce a wide range of bio-electromagnetic waves mainly in infrared range. It is used to therapy the patient's chest, spine, knee, foot and neck as well as axillae if there were lymphsdenopathy 45 min. once daily. The distance between the generator and skin is 25 cm. After the treatment, all the patients felt very comfortable. The patient's symptoms were controlled effectively. Either a clinical improvement or a weight gain of 3 Kg in 8 of l0 patients was observed at the end of four weeks. Of all 10 cases, 4 patient's total count CD4+ T cell rose significantly. 2 cases CD4+ T cell count increased slightly. And there was no increase in another 4 patients. The follow-up results indicate: one year later after the treatment, besides 1 case died of serious opportunistic infection. The symptoms reoccurred in 4 cases. 5 cases are still very health asymptomatic with the normal level of CD4 + T cell counts. We conclude that the Bio-frequency Spectrum therapy is a promising therapeutic method in patients with AIDS or AIDS-related complex. Although the precise mechanism is still unclear, the available data is encouraging. Its efficacy is currently evaluated in large-scale, controlled clinical trials. Key words: MF lamp, Bio-frequency, Spectrum, AIDS, Physiotherapy Introduction: The instrument of MF lamp (MF lamp) is an electro-magnetic-wave generator with a specific structure, which was based on the theory of resonance absorb in biophysics[l]. It can produce a broad range of frequency spectra including the near-infrared, far-infrared and very small dose of short-waves, which are similar to those of the human body's emitted to the outside. At present, all the methods used to treat AIDS and AIDS-related complex are focused on the chemical medication, vaccine and the bio-recombinant products. Because of the heterotity of HIV[2] and the complexity in the pathogenesis of AIDS, it is difficult to find the medication and vaccine with high effectiveness and little toxicity in the near future[3]. So it is necessary to develop new ways from the multi-angles in treating the AIDS patients. Based on the facts[4-6], that the MF LAMP instrument has been applied to treat hepatitis n simplex herpes and herpes zoster effectively. And the bio-effects of the MF therapy has been also indicated by the previous experiments of improvement in the immune system function[7], promoting peripheral nerve regeneration[8] and blood circulation[9]. So we applied the MF instrument to treat AIDS patient and to observe its efficacy in Bejing China, March, 1997. Subjects: 10 Chinese AIDS patients(9 males and 1 females) were enrolled in the clinical trial the average age is 39.9 years (29-60). Half to nine years had elapsed between the patient's first known HIV antibody positive and their enrollment in this study. All of them were testified HIV positive. The mode of transmission: 4 cases from homosexuality (Ho), 3 cases from heterosexuality (He), 2 cases from the blood transfusion B) and 1 case with a history of intravenous drug abuse (D) .

Table 1. Clinical Characteristics of the 10 Patients at study Entry

Patient No.    Sex Age      HIV           Signs and Symptoms
                          Infected
                           Years   Mode Fatigue Anals-Ulcer Herpes Fever

1               M   32       2      Ho      +       +        +       +
2               M   60       3      Ho      +       +        -       +
3               M   41       5      Ho      +       -        +       +
4               F   52       1/2    D       +       -        +       - 
5               M   35        2     He      +       +        +       + 
6               M   43        2     He      +       +        +       + 
7               M   42       1/2    B       +       +        +       -
8               M   35        9     Ho      +       +        +       +
9               M   29        5     B       +       +        +       -
10              M   30        4     He      +       +        +       + 

All the 10 patients possess the fatigue and magersucht in different degree. Some of them suffered from lympha denopathy, herpes, tongue ulcer and anus ulcer etc. (See table L). The average total count of CD4+ T cell is 212.5 -/+ 159.6 They had accepted the AZT treatment. Two of them stopped using AZT just before this trial began. All of them were volunteer to receive this treatment. Instruments and Method The instruments of MF Bio-frequency Lamp were supplied by doctors Some parameters in the ZL-MF LAMP are: Power: 200 W The spectrum of wavelength: 0.72-8000 micrometer. The specific absorb rate (SAR): 20 mW/cni(38W/Kg). The temperature of skin surface receiving the therapy: 40 t. The clinical evaluation were based on the comparison between the pre-treatment and post-treatment. No control group was used. At the trial beginning and end, the patient's CD4+ T cell count and the physical examination were conducted. Study duration is 4 weeks. One year later (March, 10, 1997), to do the follow-up visiting results. MF LAMP were used to therapy the patient's chest , spine, knees and foot palms, We also give therapy on the injury parts directly, such as lymphadenopathy, tongue anus ulcer and herpes. The distance between the generator and skin is 20-25 cm. Each treatment last for 45 minutes. once daily. During the trial, no medication be allowed. The clinical efficacy were determined by the following markers: 1). Comparison of the CD4 + T cell counts of each patient in pre and post treatment; 2). Improvement degree and the disappearance rate of patient's symptom and sign; 3). According to the follow-up result to observe the patient's physical condition, the reoccur rate of symptoms and signs. the stability degree of CD4 + T cell count. According to the level of CD4 + T cell count before the treatment, the 10 cases can be divided into 3 groups. After 4 weeks therapy, the CD4 + T cell count rose significantly (P < 0.05) in the first group(No.1,2,7,8). See table 2. Second group increased slightly. The third group (No. 4,5,9,10) no changes were observed.

          Total Count of CD4+ T Cell

The Result of MF Therapy in Group 1 Patients
Patients Pre-treatment. Post-treatment.      Rise
1          409            606                 197
2          355            561                 206
7          350            460                 110
8          406            535                 129

The Result of MF Therapy of Group 2 Patients
Patients   Pre-treatment   Post-treatment    Rise
3           167                191            24

The Result of MF Therapy of Group 3 Patients
Patients    Pre-treatment  Post-treatment Rise 
4            30                 18         -12
5            51                 58          7
9            7                  15          8
10           72                 46         -26

In reality we have found out that we can get a much better result to therapy the spine, foot palms, chest and knees than to radiate the other places both in clinical and basic research [10]. The results above mentioned was based on 10 cases with 4 weeks MF's therapy so about the time of treatment course and the therapy time we are doing more detail research. But we believe that the longer the time of treatment course the much better results we'll get. This report also indicated that no good correlation between the level of CD4 + T cell counts and the serious degree of disease in the end stage of AIDS. That means when the patient's symptoms disappeared or were remarkably reduced, the level of CD4 + T cell counts did not show significant increase, and sometimes decrease as shown in the third group of patients. It is assumed that the eversable value of CD4 + T cell counts is 200*lrI/L If the count value is below this level, it is difficult to increase with the MF LAMP therapy. And the more lower of this value, the more difficult of increasing the CD4 + T cell counts. The correlation coefficient between the CD4 + T cell count and the patient's health condition become lower. At the end stage of AIDS this marker can not reflect the severe lesion degree of the disease. So the comprehensive evaluation is reasonable and necessary. This is the primary report we wonder if we prolong the treatment course, the CD4 + T cells count will increase. The therapeutic mechanism of MF LAMP for AIDS may be related to the improvement of immunity function of human body and the blood circulation. As to the precise mechanism of the MF therapy on AIDS still needs further study. A suggestion to develop a MF therapeutic bed having several heads which can cover the whole body of patient has accepted by inventor and manufacturer. The plan for further study with proposed MF bed which can give the patient's whole body bio-spectrum therapy will be conducted by us shortly. 1.Zhou, Lin, Xue shan Zhang. The mechanism of bio-frequency spectrum therapy. The Data Collection of the First National Conference on Biomedical Engineering. 11,1995. 2. Matthijs Tersmette and Frank Miedema. Interactions between HIV and the host immune system in the pathogenesis of AIDS.AIDS 1990; 4(Suppl): 60-61. 3. Ann C. Collier. Clinical research 1990: a summary. AIDS 1990;4(Suppl): 15-16. 4. Dani P', Bolognesi and Geoffrey C. Schild, Vaccine and Immunology Overview. AIDS 1990; 4(suppl): 127-128. 5.Wang ahenghong, Hou shenglu, et al, Clinical observation about the effect of Bio-frequency spectrum therapy on the chronic hepatitis B. Data of The First National Conference on Bio-frequency Spectrum Therapy(FNCBSFPT) 1989; 3:41-44. 6. Cao Ping, Xiao zibin, et al, Clinical observation the effect of Bio-frequency spectrum therapy on simplex herpes and herpes zoster. Data of FNCMF LAMPT 1988; 2:45-47 7. Lin jiayou, Lugang, et al, The effect of therapy of bio-frequency spectrum instrument on the mice immunity function. Data of FNCBSFPT 1989; 3:2-3. 8. Xiao wenhuan, Xie yikuan, Exploration into the therapeutic instrument of bio-frequency spectrum therapy on peripheral neuropathy. Data of FNCMF LAMPT 1989; 3:6-10. 9. Liu xiaobuo, Jin shizhengn. The effect of bio-frequency spectrum instrument on the nail fold micro-circulation. Data of FNCBSFT 1989; 3:31-32.

UNCONTROLLED TRIAL OF TREATMENT WITH BIOFREQUENCY THERAPEUTIC INSTRUMENT (MF LAMP) IN HIV ( AIDS ) INFECTED PATIENTS ---- abbreviation

L. Zhang and K. Ren SUMMARY A limited clinical study was conducted to explore AIDS treatment by the Bio-frequency Spectrum Therapeutic Instrument (MF LAMP). MF LAMP has been shown to be safe and effective in the treatment for virus infections of herpes, influenza and hepatitis. Four cases of the treatment of AIDS patients by the MF LAMP are reported in this study. These AIDS patients showed CD4 positive cell counts decreased with time and mild infectious symptoms. After 15 treatments with MF LAMP in a period of 30 days, stability or increase in CD4 positive absolute cell count, percentage of CD4 positive cells and absolute lymphocyte count were observed in three subjects after the MF LAMP treatment. P24 antigen became undetectable in one of these three subjects. Elimination Of inflammatory Herpes lesions on the tongue and around the anus, and skin rash were evident in all cases. One subject who had 72 CD4 positive cell counts per cubic millimeter prior to the treatment showed decreased CD4 positive cell counts but showed negative hepatitis B virus surface antigen HBsAg) after being HBsAg positive for six years. This preliminary clinical study indicated that MF LAMP treatment might play an active role in improving immune function (T cell counts), eliminating mild infectious complications, especially eliminating ulcer, relieving pain, improving quality of personal life in HIV infected persons. The treatment showed no appreciable side effects at all. Encouraged by this very limited study expanded clinical trial with a Larger number trial is planned. INTRODUCTION More than 5 million people are infected with human immunodificiency virus HIV), the causative agent of the acquired immuno-deficiency syndrome(AIDS). HIV infection inevitably progresses to a fatal outcome. Progression of the disease, however, can be extremely variable [l]. Zidovudine (AZT) has shown to be effective in symptomatic and/or asymptomatic human HIV infection[2]. Hematologic abnormalities, myopathy and decreased in vitro and in vivo sensitivity of HIV to drug has been associated with extended AZT use[3-5]. Exploring safe, effective and cost-effective treatment for HIV infection remain important clinical objectives. The MF LAMP, originated by Chinese medical scientists, has shown significant effectiveness in improving immune function, reinforcing anti-inflammation, relieving pain, and enhancing tissue repairing and wound healing[6]. Significant clinical benefits of MF LAMP treatment on the virus infections of herpes. hepatitis and influenza have encouraged us to conduct this initial clinical trial of MF LAMP treatment for HIV . HIV infection progressively depleted CD4 positive helper/induce T lymphocytes(CD4 + cells) and creates an immune deficiency that accounts for the dramatically increased incidence of opportunistic infections and certain cancers in the AIDS patients[7]. In this study, we evaluated the effects of MF LAMP treatment on HIV infected subjects using HIV P24 level, CD4 + cell count, and mild infectious complications as markers. SUBJECT AND METHODS This study was designed us an initial clinical trial with no control group. Four patients from 35 to 50 years of age who where sero-positive for HIV antibody for 1-3 years, were enrolled. These patients exhibited enlarged lymph nodes at two or more sites, decreased absolute CD4 + cell counts, decreased percentage of CD4 + cells and the ratio of CD4/CD8. At entry, the subjects' neuro-psychiatric function was normal but severely depressed. Besides, subject 1 had fungus infection on his right foot; Subject 2 had Herpes Zoster lesion on his face and veneroid anal ulcer; Subject 3 had Hepatitis B virus (HBV) and Herpes Zoster virus (HZV) infection for 6 years with Herpes relapse about once about five weeks and veneroid anal ulcer (Fig. 1) while subject 4 had systemic skin rash, Hepatitis C virus infection and mild lung infection. All subjects received 15 MF LAMP treatments in a period of 30 days. Each treatment has a few 20 minutes therapy on the selected portions of the body (top head, chest, spinal cord and foot palms) and the inflammatory lesions. To evaluate the effects of the MF LAMP treatment, primary and secondary measures of efficacy were used. The primary efficacy criteria were based on changes of mild infectious complications. The secondary measures were based on HIV P24 antigen level and/or CD4+ cells as well us other hematological parameters. RESULTS Absolute CD4 + cell counts, percentage of CD4 + cells and absolute lymphocyte counts were stabilized or increased in three subjects, but decreased in CD4 + cell count in one subject. The ratio of CD4/CD8 was increased in two subjects and decreased in others. The value of P24 antigen become undetectable on the subject 1, the only one who had this measurement. The lymphadenopathy was completely gone in all subjects. during the MF LAMP treatment all subjects were experiencing a feeling of optimism and renewed strength. Fungus infection was completely eliminated in the case L At the end the clinical trial , the case 2 gained 206 CD4+ cells count, 71 CD20+ (Bl) cell count, 689 CD2+ (Tll), 300 CD8 + (T8), 405 CD3 + (D) cell count and 40 CD56(NKH) cell count per cubic millimeter; Herpes lesion and veneroid anal ulcer were completely gone. Such results have kept constant sixteen weeks after the termination of the treatment. After fifteen treatments the case 3 lost 56 CD4+ cells 211 CD8+ cells. However, his serum HBsAg testing became negative and his anal-lesion was completely gone(Fig.2) and had no Herpes relapse for eight weeks. The case 4 completely recovered from skin rash, mild lung infection and Herpes lesion, and showed an increase in CD4 + cells. However, his hepatitis C virus infection remained unchanged. The treatment had no effect on red blood cells; increases in hemoglobin was observed. DISCUSSION The present study indicated that the MF LAMP treatment plays an active role In normalizing immune function, eliminating certain inflammatory and infectious complications, relieving pain and suffering and improving personal life in HIV infected persons. In early 1994, Dr. Lin, zhou first proposed that Bio-spectrum of the human body might have positive effect in life of AIDS patients. The apparatus which can generate simulated Bio-spectrum of the human body was invented and applied to AIDS patients. Extensive studies of the MF LAMP treatment have been conducted and significant clinical benefits have been indicated in treating infectious diseases of hepatitis, herpes and influenza. It was hypothesized that the generated simulated MF LAMP can get into the body through resonance and body cells e.g. cells in immune system, nervous system, organs and tissue) can absorb this bio-energy to activate biochemical and physiological processes of all levels (electronic level. atomic level, molecular level and body fluids (blood and other level) to repairing and tissue to neurohumoral regulation, immune system, blood and other body fluids circulation are strengthened and improved for speed-up healing. The therapeutic effectiveness of the MF LAMP for viral diseases seems by strengthening immune system fighting against viruses. It is still too early to conclude the value of the MF LAMP therapy. Nevertheless, it indicates the advantages of not causing any side effects , being very simple to use, having low costs as well as being for overall well-being. Most important, it shows strong indication of clinic benefit in HIV infected Subjects, or at least improvement in the life quality of AIDS patients. REFERENCES 1. Mann, J. M., J. Acquir. Immune Syndr. 2. Friedland, G. H., New Engl. J. Med., 322 1000-1002, 1990 3. Richman, D. D., Sischl, . New Engl.J. Med. 317-, 192-197, 1987 4. Dournon, E, Matheron, W., et al., Lancet, 2, 1297-1302, 1988 6. Zhou L. et al., Abstr. 1st spectrum Medicine, Beijing, Nov. 12-17, 9-56, 1989 7. Bowen, D. L, Lane. H. C. Ann, Intern. Med., 103,704-709, 1985 8. Zhou L, Abstr. 1st National Biofrequency spectrum Medicine, Beijing, Nov. 12-17n 2-3n 1989 Acknowledgements: The Authors thank administrators, doctors, and staffs at The Health Education AIDS Liaison, New York for their assistance Note: Both articles are from the 17th Conference of National AIDS Research Foundation of China, Oct. 1997.